Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients
European Journal of Cancer · 2026-03 · 236 · 116262
DOI: 10.1016/j.ejca.2026.116262 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von Ingrid A Franken und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Smad4 Protein, Colonic Neoplasms, Mutation, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stand up to Cancer, Health~Holland, KWF Kankerbestrijding.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Laboratory of Translational Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands.
- Department of Surgery, Leiden University Medical Centre, the Netherlands.
- Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.
- Labcorp Oncology, Baltimore, MD, USA.
Förderung
- Stand up to Cancer
- Health~Holland
- KWF Kankerbestrijding
- Maag Lever Darm Stichting
Zitieren
APA
Franken, I. A., Ketelaars, S. L. C., Rubio-Alarcón, C., Delis-van Diemen, P., Spaapen, T. O. M., Heilijgers, F., da Silva Guimaraes, M., van Nassau, S. C. M. W., Schraa, S. J., Mesker, W. E., de Leng, W. W. J., Kranenburg, O., Meijer, G. A., Koopman, M., Sausen, M., Vink, G. R., Abeln, S., Fijneman, R. J. A., Roodhart, J. M. L., & PLCRC-MEDOCC group (2026). Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients. European Journal of Cancer, 236, 116262. https://doi.org/10.1016/j.ejca.2026.116262
Vancouver
Franken IA, Ketelaars SLC, Rubio-Alarcón C, Delis-van Diemen P, Spaapen TOM, Heilijgers F, et al. Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients. European Journal of Cancer. 2026;236:116262. doi:10.1016/j.ejca.2026.116262
BibTeX
@article{Franken2026,
author = {Franken, Ingrid A and Ketelaars, Steven L C and Rubio-Alarcón, Carmen and Delis-van Diemen, Pien and Spaapen, Tessa O M and Heilijgers, Floor and da Silva Guimaraes, Marcos and van Nassau, Sietske C M W and Schraa, Suzanna J and Mesker, Wilma E and de Leng, Wendy W J and Kranenburg, Onno and Meijer, Gerrit A and Koopman, Miriam and Sausen, Mark and Vink, Geraldine R and Abeln, Sanne and Fijneman, Remond J A and Roodhart, Jeanine M L and PLCRC-MEDOCC group, PLCRC-MEDOCC group},
title = {Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients},
journal = {European Journal of Cancer},
year = {2026},
volume = {236},
pages = {116262},
doi = {10.1016/j.ejca.2026.116262}
}
EUVIMED